This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mvrix Co., Ltd.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jinhyo Chung: Innovator in Viral Receptor Technology
Introduction
Jinhyo Chung is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of viral receptor technology, focusing on innovative solutions for viral infections. His work is characterized by a unique approach that combines biochemical compounds to enhance binding affinity to viruses.
Latest Patents
Jinhyo Chung holds a patent for a viral receptor bound with sialic acid compounds. This invention discloses a viral receptor that contains a sialic acid compound on one side to provide binding affinity to a virus, while incorporating a lipid on the other side. This innovative design can be widely utilized for the treatment of viral infections, showcasing its potential impact on public health.
Career Highlights
Chung is currently associated with Mvrix Co., Ltd., where he continues to develop groundbreaking technologies. His work at Mvrix reflects his commitment to advancing medical science and improving therapeutic options for viral diseases.
Collaborations
Some of his notable coworkers include Caleb Hong and Woo Jae Chung, who contribute to the collaborative environment at Mvrix Co., Ltd. Their combined expertise fosters innovation and drives the development of new technologies.
Conclusion
Jinhyo Chung's contributions to viral receptor technology exemplify the importance of innovation in addressing health challenges. His patent and ongoing work at Mvrix Co., Ltd. highlight his role as a key player in the field of medical research.